"PVG's recent share price weakness delivers an investment opportunity."

–Eric Zaunscherb, Canaccord Genuity

"PVG's Brucejack project has now become a mine."

–Heiko Ihle, H.C. Wainwright & Co.

"If successful, POE's AYU-1 could substantially impact the stock price."

–Bill Newman, Mackie Research Capital

"RP announced its participation in the ThawSTAR Early Adopter Program."

–Douglas Loe, Echelon Wealth Partners

"PVG's Brucejack asset showed well on day one of site tours this week."

–Jeff Killeen, CIBC World Markets

"Hole 295 at CGT's Montagne d'Or returned 41m grading 0.92 g/t gold."

–Gwen Preston, Resource Maven

"A revised mine plan for MAG's Juanicipio is expected in Q3/17."

–Bhakti Pavani, Euro Pacific Capital

"MAG's JV ground offers additional exploration upside."

–Chris Thompson, Raymond James

"We are resuming coverage on TV with an Outperform rating."

–Brian MacArthur, Raymond James

"FCU completed its summer 2017 PFS drilling; results were impressive."

–Heiko Ihle, H.C. Wainwright & Co.

"Drilling at GPR's Coricancha extended known high-grade areas."

–Heiko Ihle, H.C. Wainwright & Co.

"The acquisition from Glencore will more than double the size of TV."

–Jeff Woolley, Paradigm Capital

"We reiterate our Top Pick rating on TV."

–Stefan Ioannou, Cormark Securities

"DRRX confirmed that it expects to complete patient follow-up visits this quarter, and announce top-line results from the Phase 3 PERSIST study in 4Q17."

–Ed Arce, H.C. Wainwright & Co.

"CGT has a very powerful exploration partner in Nevada."

–The Gold Report Interview with James Kwantes

"NXE is really positioned to take a dominant place in the world's uranium sector."

–The Gold Report Interview with James Kwantes

"PVG's Brucejack is high grade, but also has size."

–The Gold Report Interview with James Kwantes

"PVG produced 25,392 oz gold at Brucejack during commissioning."

–Heiko Ihle, H.C. Wainwright & Co.

"We believe VIVE's Phase 3 trial is on track for a readout of data in mid-2019."

–Anthony Vendetti, Maxim Group

"We believe that VIVE is currently in discussion with the agency and that a formal IDE would be submitted in the coming months such that a study (VIVEVE II) would commence in late 2017."

–Jeff Cohen, Ladenburg Thalmann